Molecular pathogenesis of Fanconi anemia

范可尼贫血的分子发病机制

基本信息

  • 批准号:
    16590928
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Fanconi anemia (FA) is a genetically heterogeneous inherited disorder characterized by bone marrow failure and congenital anomalies. Although an increasing number of reports suggest that reverse mosaicism noted in peripheral blood lymphocytes (PBL) is associated with mild hematopoietic failure in FA, direct examination of myeloid cells have been done in few cases. We found a patient with prolonged mild pancytopenia in whom proliferation of revertant cells was detected in mature myeloid cells but not in PBL. While this patient had inherited heterozygous mutations, 2546delC and 3720-3724del, in the major Fanconi anemia gene FANCA, lymphoblastoid cells from the patient had 2546C>T instead of 2546delC, resulting in expression of a functional missense protein. Since the identical reversion was detected in polymorphonuclear granulocytes and mononuclear phagocytes, sustained hematopoiesis in the patient is attributed to selective growth advantage of revertant myeloid cells. It is noteworthy t … More hat such a myeloid lineage-selective mosaicism is overlooked in routine examination of PBL. Recognition of this status will expand the role of reverse mosaicism in the pathophysiology of FA. Bone marrow failure in FA often shows progression to myelodysplastic syndrome (MDS) and leukemia, which may be attributed to mutations of oncogenes and tumor suppressor genes based on DNA repair deficiency. However, specific mutations of these genes have not been identified in FA leukemic cells. We hypothesized that epigenetic abnormalities may be associated with the pathophysiology of FA. To address this question, we analyzed promoter methylation of five tumor suppressor genes, p15, p16. DAP kinase, RAR-β, E-cadherin. The results showed that 8 of 11 patients (72.7%) had hypermethylation in one or more of these genes. The methylation abnormalities were observed more frequently in patients with MDS than in those without MDS. These results suggest that epigenetic abnormalities might be involbed in leukmogensis in FA. Less
Fanconi贫血(FA)是一种遗传性异质遗传疾病,其特征是骨髓衰竭和先天性。 Re Myloid细胞,但在PBL中不遗传杂合突变,2546delc和3720-3724del,在您的主要fanconi贫血基因基因上,患者的淋巴细胞细胞具有2546c> t在多形核中检测到相同的反向,而单核的吞噬细​​胞归因于恢复的髓样细胞的选择性生长优势。基于DNA修复的进展激酶,RAR-β,E-cadherin。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular Mechanisms of Fanconi Anemia
范可尼贫血的分子机制
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yamashita T;et a1.
  • 通讯作者:
    et a1.
Myeloid lineage-selective growth of revertant cells in Fanconi anemia.
范可尼贫血中回复细胞的骨髓谱系选择性生长。
Identification and characterization of the major Fanconi anemia gene FANCA in the Japanese population.
日本人群中主要范可尼贫血基因 FANCA 的鉴定和特征分析。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yagasaki H;Yamashita T;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMASHITA Takayuki其他文献

YAMASHITA Takayuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMASHITA Takayuki', 18)}}的其他基金

Roles of replication stress for cellular senescence and genome instability in preneoplastic lesions
复制应激对肿瘤前病变中细胞衰老和基因组不稳定性的作用
  • 批准号:
    23501257
  • 财政年份:
    2011
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Dynamics of the Population and the Transformation of Regional Economies
人口动态与区域经济转型
  • 批准号:
    21530257
  • 财政年份:
    2009
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New understanding and therapeutics of hematopoietic diseases-from a viewpoint of regulatory mechanisms of replicative stress
造血系统疾病的新认识与治疗——从复制应激调控机制的角度
  • 批准号:
    20591109
  • 财政年份:
    2008
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the structure and function of single active zone using two-photon microscopy
双光子显微镜分析单个活性区的结构和功能
  • 批准号:
    20700357
  • 财政年份:
    2008
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Study of molecular pathogenesis of Fanconi anemia
范可尼贫血的分子发病机制研究
  • 批准号:
    14570963
  • 财政年份:
    2002
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the molecular mechanisms of chromosome instability and development of MDS/AML
染色体不稳定与MDS/AML发生的分子机制研究
  • 批准号:
    11670982
  • 财政年份:
    1999
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

范可尼贫血症中骨髓衰竭的致病机理研究
  • 批准号:
    32071285
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
人类核糖体病中骨髓衰竭和白血病发生的机制研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    10 万元
  • 项目类别:
    国际(地区)合作与交流项目

相似海外基金

Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Emerging Mechanisms of Replication-coupled DNA Repair
复制耦合 DNA 修复的新兴机制
  • 批准号:
    10720698
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Understanding the aging process in hematopoietic stem cells by alcohol-induced DNA damage
了解酒精诱导的 DNA 损伤造血干细胞的衰老过程
  • 批准号:
    10811164
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
FANCC mutation correction using homology-independent targeted integration for gene therapy of Fanconi Anemia group C
使用同源无关的靶向整合校正 FANCC 突变,用于范可尼贫血 C 组的基因治疗
  • 批准号:
    10653342
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Mechanism of radial chromosome formation in human premature aging syndrome cells
人类早衰综合征细胞放射状染色体形成机制
  • 批准号:
    10793247
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了